Tagged Articles

litigation 1089 articles

Xarelto bleeding victim fights drugmakers’ motion to throw out case

A man suing Johnson & Johnson’s Janssen Pharmaceuticals and Bayer over Xarelto bleeding risks pushed back against the drug companies after they asked the judge overseeing the case in Philadelphia to drop the case because his prescribing doctor testified he did not read Xarelto’s safety label. Daniel Russell argued that the focus should not be on that doctor – Dr. Riple Hansalia – because he was simply continuing a prescription made by another physician – Dr. Ihab Girgis – the day before. Thus, Dr. Girgis should be considered the relevant prescriber under the law, Russell argued. Furthermore, Dr. Hansalia may ... Read More

Beasley Allen files opioid lawsuits on behalf of more AL cities, counties

Beasley Allen Law Firm has filed additional lawsuits against manufacturers and distributors of opioid painkillers on behalf of two Alabama cities and two Alabama counties. The lawsuits blame opioid makers and distributors of creating an opioid epidemic, a public health and safety crisis that is financially burdening communities and killing citizens. The lawsuits were filed in April on behalf of the cities of Tuskegee and Weaver, as well as Henry County and Cleburne County. Beasley Allen has filed similar lawsuits on behalf of other Alabama municipalities and counties, as well as governmental entities in several other states including Tennessee and ... Read More

Janssen, Bayer ask judge to toss latest Xarelto side effects trial

Johnson & Johnson’s Janssen Pharmaceuticals and Bayer asked a Philadelphia judge to toss a case currently in trial blaming the drug companies for not adequately warning about bleeding risks with their blood thinner Xarelto, arguing that there is no evidence that the prescribing physician in the case would have given the plaintiff a different medication if stronger warnings had been on the label, because he testified he didn’t even read the drug’s label. As a result, Janssen and Bayer argued, the plaintiff doesn’t have a case. The trial involves the case of Daniel Russell, who in April 2013 had a ... Read More

Women seek centralization of Taxotere hair loss lawsuits

About 350 women suing Sanofi-Aventis and other drug companies for failing to warn about the risk of permanent hair loss from the breast cancer drug Taxotere are calling for the New Jersey Supreme Court to designate the lawsuits as a multicounty litigation under Superior Court Judge James F. Hyland in Middlesex County. Centralizing the lawsuits was recommended because of the large number of cases and the common issues in their claims. Centralized management would conserve judicial resources, provide all those involved with the benefits of coordinated discovery, and minimize duplication, the petition states. The vast majority of the state lawsuits are ... Read More

J&J faces more litigation alleging injuries with Physiomesh

A group of people who claim to have been injured by hernia repair kits made by Johnson & Johnson subsidiary Ethicon USA LLC have asked the New Jersey Supreme Court to consolidate the 62 lawsuits pending against the company into a multicounty litigation, and assign them to Superior Court Judge Rachelle Lea Harrz in Bergen County. Several hundred similar cases are expected to be filed. Those suing Ethicon allege the company designed, manufactured, marketed and sold defective hernia mesh, including Proceed Surgical Mesh, Proceed Ventrical Patch, Ethicon Physiomesh Flexible Composite Mesh, Prolene 3D Patch Polypropylene Mesh, and Prolene Hernia System. ... Read More

Judge overseeing opioid MDL orders DEA to share information on opioid sales

The Ohio federal judge overseeing the massive multidistrict litigation involving local governments accusing pharmaceutical companies, drug distributors and pharmacies of fueling the opioid epidemic laid out timelines for an active litigation phase to work through difficult legal issues in order to expedite a settlement in the case. The Judge also directed the Drug Enforcement Administration (DEA) to pony up information about the sales of opioids, something the DEA has been reluctant to do. In addition to the two orders, U.S. District Judge Dan Aaron Polster also consolidated three lawsuits in the MDL brought by Ohio local governments and scheduled them ... Read More

Second Xarelto trial underway in Philadelphia County

The second case among more than 1,700 in a mass tort program in Philadelphia County Court of Common Pleas over claims that the blood thinner Xarelto caused seious harm to patients, is scheduled to go to trial this week. The trial involves the case of Daniel Russell, who was prescribed Xarelto in May 2013 to prevent strokes after he was hospitalized with a heart condition. Seven days into his Xarelto treatment, Russell suffered a gastrointestinal bleed. He claims his major bleeding event was caused by Xarelto because at the time he was prescribed the drug he was already taking two ... Read More

Securities class action filed on behalf of J&J investors

A class action lawsuit has been filed on behalf of Johnson & Johnson investors who purchased or otherwise acquired Johnson & Johnson securities between Feb. 22, 2013, and Feb. 7, 2018. The investors claim that the company made false or misleading statements or failed to disclose that it has known for decades that its talc-containing products like Johnson’s Baby Powder and Shower to Shower contain asbestos fibers and that exposure to the products can cause ovarian cancer and mesothelioma. The Johnson & Johnson investors have until April 9, 2018, to file a lead plaintiff motion. The complaint references a Feb. ... Read More

Jury enters deliberations in first Bard IVC filter trial

Jury deliberations have begun in the first bellwether trial in a multidistrict litigation (MDL) against C.R. Bard over claims that its blood clot-catching device fractured and migrated inside a patient’s body causing serious and life threatening injuries. Plaintiff Sherr-Una Booker was 37 when she was implanted with Bard’s G2 IVC filter to protect her from pulmonary embolism, or blood clots in the lungs. The G2 is a small cage-like device that is implanted into the inferior vena cava, a large vein that carries deoxygenated blood from the lower extremities. It is designed to capture blood clots before they reach the ... Read More

AbbVie faces fourth testosterone side effects trial

AbbVie Inc. will continue to use deceptive practices to market its testosterone replacement therapy AndroGel unless it is sent a firm message and faces financial pressure, say attorneys for a man who blames his heart attack on the drug. The jury in the fourth bellwether trial against AbbVie in a multidistrict litigation heard testimony alleging testosterone manufacturers did not adequately warn of cardiovascular risks with their testosterone treatments. Jesse Mitchell’s case was the first to go to trial and accuse AbbVie of failing to warn that AndroGel could increase the risk of heart attacks, strokes and blood clots, some of ... Read More